DENALI THERAPEUTICS INC.
Last · NASDAQ$17.87-0.53 (-2.88%)close · yahoo · 15h ago
Vol 2.70M ≈ 48.31M
MA10MA20MA50
Market cap$2.86B159.8M sh
P/E · TTM-6.3fwd -7.4 · eps -2.84 · loss
Beta1.02vs S&P 500
Div yield0.00%annual · TTM
52w range
$13.75$27.30
Volume2.7Msession
Issuer
Legal nameDENALI THERAPEUTICS INC.
HQUnited States (US)
ListingUS DNLI
ISINUS24823R1059
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001714899
CIK0001714899
Websitewww.denalitherapeutics.com
Employees507
AddressDenali Therapeutics, Inc. 161 Oyster Point Boulevard 94080, San Francisco +650 866 8547
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-02-26
From latest 10-K · 2026-02-26
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -43.9%
- Cash Runway Low — Cash runway ~0.5 years
- Accumulated Deficit High — Accumulated deficit / equity 202%
Upcoming earnings
THU.5NOV
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.37
Est. revenue
22.9M